Next Article in Journal
Functional Expression of NMDA Receptors in SH-SY5Y Neuroblastoma Cells Following Long-Term RA/BDNF-Induced Differentiation
Previous Article in Journal
A Confirmatory Factor Analysis of the Dementia Attitude Scale (DAS) in a European Case Series of Caregivers of People with Dementia Enrolled in the RECage Study
Previous Article in Special Issue
Intensive Speech Therapy for Hypokinetic Dysarthria in Parkinson’s Disease: Targeting the Five Subsystems of Speech Production with Clinical and Instrumental Evaluation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
NeuroSci
Volume 6
Issue 2
10.3390/neurosci6020046
neurosci-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Meta-Analysis of Exercise Effects on Cognition in Persons with Parkinson’s Disease

by
Syed O. Ahmad
1,2,*,
Dana Stiles
3,
Kaylee Brown
1,
Leah Dillon
1 and
Eliza Shroba
1
1
Department of Occupational Science and Occupational Therapy, Neuroscience Core Faculty, Saint Louis University, St. Louis, MO 63103, USA
2
Virginia Gore NeuroOccupation Lab, Inc., St. Louis, MO 63017, USA
3
Office of Institutional Research, Saint Louis University, St. Louis, MO 63103, USA
*
Author to whom correspondence should be addressed.
NeuroSci 2025, 6(2), 46; https://doi.org/10.3390/neurosci6020046
Submission received: 20 February 2025 / Revised: 1 May 2025 / Accepted: 6 May 2025 / Published: 23 May 2025
(This article belongs to the Special Issue Parkinson's Disease Research: Current Insights and Future Directions)
Browse Figures
Versions Notes

Abstract

Background: Parkinson’s disease (PD) is a debilitating neurodegenerative disorder affecting millions of people worldwide. PD results in motor and cognitive dysfunction. While there is no proven cure for PD, it is widely agreed that aerobic exercises and occupations can help slow the progression of the disease and keep some motor-related symptoms from developing. The most effective forms of exercise to slow the progression of motor symptoms in Parkinson’s disease have also been studied. Research Question: This research article aims to compare the differences in outcomes of exercise on cognitive outcomes in Parkinson’s Disease, as evaluated by meta-analysis. Methods: Key terms were Parkinson’s Disease and exercise terms. These search terms were then entered to electronic databases—Ovid MEDLINE, SCOPUS, and CINAHL—from March 2018 to May 2023. An ancestral bibliography was also performed. Results: Two reviewers screened the title and abstract records (n = 528) found in the initial search. Our review identified 18 studies which met inclusion criteria for meta-analysis. The meta-analysis found an effect of exercise on cognition of patients with PD (d = −0.03) which was not significant (CI95% of −0.13 < µ < 0.08; p > 0.05, as the CI includes zero). Additionally, the homogeneity analysis was not significant (Q (17) = 2.83; p > 0.05).

1. Introduction

Parkinson’s disease (PD) is a debilitating progressive neurodegenerative disorder affecting millions of people worldwide. PD results in both cognitive and motor dysfunction, featuring symptoms such as bradykinesia, postural instability, muscular rigidity, speech disturbances, dystonia, sleep disturbances, pain, and anxiety [1,2,3,4]. It has been long known that exercise has benefits for the motor deficits in PD, and this database was used to find a positive result utilizing Unified Parkinson’s Disease Rating Scale (UPDRS) motor scores [1]. Exercise appears to enhance neuroplasticity by increasing the production of brain-derived neurotrophic factor (BDNF), a protein linked to improved learning, memory, and resilience against neurodegeneration [5,6,7,8,9]. Studies show that aerobic exercise, in particular, improves brain function and delays cognitive decline by promoting blood flow to the brain, enhancing oxygen and nutrient delivery to regions like the hippocampus, which is crucial for memory [7].
Exercise and cognition have been studied in the past for Parkinson’s disease, and some of the outcomes have been positive [10], looking at treadmill activities and the initiation and severity of symptoms. Recent meta-analyses have been performed on factors associated with sedentary activity and progression [11], which found improvement in non-motor scores, including for cognition. A recent systematic review of seven studies found negative cognitive outcomes from sedentary activities on cognition in PD [12]. Non-motor effects of non-pharmaceutical therapies were meta-analyzed to find positive results (cognition among several non-motor symptoms) [13]. This conclusion was supported by research which found that the pattern and style of exercise did not show differences in PD symptomatology, but resulted in overall improvement [10].
The effects of exercise on cognition and exercise have been variable. In a multi-disciplinary study of intensive rehabilitation, cognitive improvements were noted, though not isolated to the exercise portion, and additional non-reported cognitive interventions were utilized [9] Basdisarre). Insignificant correlations between exercise, cognitive training, and subcortical disease were found in a recent systematic review [14]. A systematic review that reached farther back in time found inconclusive and confounding results for exercise, cognition, and PD [15]. This justifies a further look into the phenomenon.
This database was chosen for its range of activities and its focus on diagnosed PD (excluding other basal brain motor dysfunction), and was used to compare endurance-based activities with occupation-based activities to show there were identical motor improvements between the groups [2,3]. Motor outcomes for this dataset were previously reported, and this analysis took the initial set of papers and further examined the Montreal Cognitive Assessment (MoCA) and Trailmaking A outcomes in the same PD groups [1]. MoCA, The Montreal Cognitive Assessment (MoCA), is a validated cognitive screening tool that can be used to screen for CI. It is a brief, 30-item questionnaire that assesses different cognitive domains, including executive function, language, orientation, memory, and visuospatial abilities [16]. It is designed to be a quick and easy-to-administer assessment tool that can be completed in approximately 10 min by trained personnel. The MoCA has also been validated in various clinical settings against neuropsychological batteries, demonstrating reliability and validity in detecting Mild Cognitive Impairment (MCI) and dementia [16,17].
Parkinson’s disease and Alzheimer’s disease often co-occur [18]. Several genetic variations have been identified for both PD and AD, but the underlying mechanisms of the gene profile are largely unknown [19]. The likelihood of an individual developing PD or AD results from the interaction between genetic and nongenetic factors over the person’s lifetime, and demonstrates statistically related impairment [19]. PD and AD often co-occur, highlighting a complex relationship between their pathologies. PD primarily affects motor function due to dopamine neuron degeneration in the substantia nigra and related cognitive impairments, and the proteopathies include Lewy body cellular inclusions [20]. The profile of disability differs in AD, and affects memory and cognitive abilities; the proteopathies include beta-amyloid plaques and tau neurofibrillary tangles in the brain [21]. Studies suggest overlapping mechanisms, such as protein misfolding, mitochondrial dysfunction, neuroinflammation, and oxidative stress, may contribute to co-occurrence [21]. In spite of the differences in pathology, cognitive and executive functioning impairments being common to both diseases, rehabilitative approaches and treatment have been similar for both disorders, which makes rehabilitative approach an area that requires more exploration.
Problem Statement: This research article aims to compare the differences in outcomes of exercise on cognitive outcomes in Parkinson’s disease, as evaluated by meta-analysis.
Hypothesis 1:
Exercise interventions will have positive cognitive results for PD, similar to positive results seen for AD. Null hypothesis: exercise does not significantly affect cognitive decline in people with PD.

2. Materials and Methods

Multiple a priori criteria were used to determine the inclusion and exclusion of the studies considered for our meta-analysis. All studies had to examine the effect of activity on cognition-related outcomes of Parkinson’s Disease. For cognition-related outcomes, data were measured by the MoCA or Trail Making Test Part A to be considered for inclusion. For the purpose of this analysis, physical intervention included activities such as dance, yoga, treadmill training, archery, water sports, and aerobic exercise, as well as many others. In order to be selected for meta-analysis, all studies were reviewed and selected for inclusion if they meet the following criteria.
  • Included individuals with a Parkinson’s disease diagnosis.
  • Performed assessment using Trail Making Tests Part A, or the MoCA.
  • Excluded dual-task interventions.
  • Used a physical activity for treatment or intervention.
  • Written in the English language, and full text available.
  • Published in a peer-reviewed journal.
  • Published between 2018 and October 2023 (these are the dates the database spans).
Studies were excluded if they did not meet all of the inclusion criteria or if they studied only animals.

2.1. Literature Search

Our review of the literature began with the formulation and selection of key search terms. These terms were Parkinson’s Disease and exercise terms (e.g., dancing, aerobic exercise, endurance exercise, yoga, swimming, and boxing). These search terms were then entered simultaneously to search for literature across three electronic databases: Ovid MEDLINE, SCOPUS, and CINAHL. These databases were systematically searched in October 2023. An ancestral bibliography was also performed using selected bibliographies.

2.2. Review Process

The search yielded 684 citations based on our inclusion criteria of being written in the English language, of studies being performed on humans, and of being specific studies (clinical trials, randomized trials). After duplicates were removed, a total of 523 articles remained. Two researchers screened the titles and abstracts of the articles, ruling out 313 records, with 210 remaining for further assessment. The remaining articles had their full-text assessed for eligibility based on the inclusion of results of tests including the Unified Parkinson’s Disease Rating Scale, Montreal Cognitive Assessment, or the Trail Making Test A. Of the articles reviewed, 115 did not include any of the included standardized assessments, leaving 95 articles. Additionally, 3 were excluded due to not having pre-intervention test results, 27 for not having post-intervention test results, 13 for not having pre- or post-intervention results, and 1 was excluded due to not having a control group consisting of individuals with Parkinson’s disease. Furthermore, 33 were excluded as they focused on motor exercises instead of cognitive exercises. With this, 18 articles were selected for inclusion into the study [see Table 1]. The summary of the review process can be found in the PRISMA chart (see Figure 1).

2.3. Meta-Analysis Calculation Formulae

d i = χ 1 − χ 2 S D 1 + S D 2 2
w i = 2 n i 1 + n i 2 n i 1 n i 2 2 n i 1 + n i 2 2 + n i 1 n i 2 d i 2
d = ∑ d i w i ∑ w i
95 % C I = d i   ± 1.96   1 ∑ w i
Q = ∑ d i 2 w i − ∑ w i d i 2 ∑ w i
I 2 = ( Q − d f ) / Q   ∗   100 %

3. Results

Our review identified 18 studies which met inclusion criteria for meta-analysis. The meta-analysis, which focused only on exercise’s effects on cognition, found a negative overall effect of exercise on cognition in patients with PD (d = −0.03), and was not significant (CI95% of −0.13 < µ < 0.08; p > 0.05, as the CI includes zero) [see Table 2 and Figure 2]. Intervals that include zero are non-conclusive and non-significant. Additionally, the homogeneity analysis was not significant (Q (18) = 2.83, p > 0.05). Further, the heterogeneity analysis, I2 = −501%, was negative and thus equivalent to 0% heterogeneity, suggesting that all variability in the study effect-size estimates is due to sampling error, and, therefore, no observed heterogeneity [40,41]. Thus, we accept the null hypothesis, that exercise does not significantly affect cognitive decline in people with PD.

4. Conclusions

With the acceptance of the null hypothesis, it begs the following question: why does exercise improve cognition in AD, but not in PD? Regular physical activity, particularly aerobic and resistance training, have been shown to significantly enhance neuroplasticity, which refers to the brain’s ability to adapt, reorganize, and form new neural connections associated with aging conditions [42]. Exercise has been found to improve executive brain function. This includes key cognitive processes like problem-solving, planning, and multitasking, which have been shown to slow the progression of cognitive decline often associated with PD and AD [43]. Alzheimer’s disease (AD) and Parkinson’s disease (PD) are also characterized by abnormal protein aggregation and progressive neuronal loss [44]. AD is associated with amyloid-beta plaques and neurofibrillary tangles composed of hyperphosphorylated tau protein affecting the hippocampus and cerebral cortex, leading to memory loss and cognitive decline [44]. PD involves α-synuclein aggregates forming Lewy bodies in the substantia nigra, causing dopaminergic neuronal loss and motor symptoms [45]. Growing evidence shows that Alzheimer’s disease-related pathologies such as tau and amyloid beta also play a role in PD, especially for cognitive impairment in PD [46]. Despite these distinct pathologies, both diseases often impact overlapping brain regions, such as the hippocampus and cortex, in later stages of PD, and the basal forebrain, in AD. The overlapping mechanisms complicate the diagnosis and treatment but underscore the need for integrated research to better understand shared pathways and develop therapies addressing both conditions (AD and PD).
It has been seen, in vitro, that the role of inflammation in neurodegenerative disorders with genetics plays an important role in this relationship [47]. Significant correlations have been observed between the levels of cerebrospinal fluid tau and A-beta with cognition status, as well as between Apolipoprotein E and microtubule-associated protein tau (MAPT) genotypes in PD [46]. Dysregulation of cholesterol metabolism has been implicated in the pathogenesis of AD and PD [44]. With the use of phytosterols, improvements have been seen in reducing cholesterol levels [44]. Other studies have shown that phytosterols have an anti-inflammatory and antioxidant effect, changing the pathologies of AD and PD [44]. Studies suggest that physical activity stimulates the production of brain-derived neurotrophic factor (BDNF), a protein that plays a vital role in supporting the growth, survival, and repair of neurons [6,7,8]. Elevated levels of BDNF, coupled with improved cerebral blood flow from exercise, enhance the health of brain regions critical for memory, attention, and decision-making, such as the hippocampus and prefrontal cortex [6,7,8]. Research indicates that regular physical exercise has significant benefits for cognition in individuals with Alzheimer’s disease (AD) [5]. Additionally, exercise helps reduce neuroinflammation and oxidative stress, both of which contribute to Alzheimer’s pathology [6]. Research suggests that consistent moderate-intensity physical activity can slow the progression of cognitive symptoms in AD. Though applied similarly, this study indicates that the mechanism for cognitive decline differs significantly in PD than AD, though the functional cognitive limitations are similar. This requires therapists and researchers to seek activities that more directly address the cognitive decline in PD, so results start to match those in AD.
In addition to aerobic and resistance exercises, structured programs like tai chi, dance, and yoga offer unique cognitive and motor benefits [2]. This database was used to compare the two approaches, and found significant differences in motor outcomes, regardless of the approach [2]. These activities not only improve balance, flexibility, and coordination—key motor challenges in PD—but also incorporate elements of rhythm, concentration, and learning of new movement patterns, providing mental stimulation—key cognitive challenges in both AD and PD [1,42]. Dance, for instance, combines physical activity with music, which has been shown to engage multiple brain areas simultaneously, fostering both motor and cognitive improvements. Similarly, tai chi emphasizes slow, deliberate movements and mindfulness, which can enhance focus and reduce stress, further benefiting cognitive health. Yoga promotes relaxation, breathing control, and body awareness, which contribute to overall brain health. The meta-analysis results are surprising, given the similarity of cognitive deficits and the inability to move the needle in PD, as opposed to positive results in AD across the literature [2]. Key occupational and physical therapy interventions use practice models, such as the neuro-occupation model, which design rehabilitation treatment approaches based on mechanisms of neuroplasticity that drive cognitive changes through performing exercises and activity. Exercise and brain adaptability is crucial for maintaining cognitive function and countering the effects of neurodegeneration in degenerative conditions, such as AD and PD. However, clinically, rehabilitation follows similar cognitive retraining and activities for both diseases, assuming similar mechanisms of disease etiology and progression.
The key takeaways from this meta-analysis are as follows: first, regardless of activity (endurance-based or occupation-based), exercise has positive effects for motor scores in PD, but not in cognitive scores. Second, more research needs to be performed on the mechanistic overlap between PD and AD, in order to develop more effective rehabilitative strategies for the treatment of clients with PD.
The limitations of this meta-analysis are, firstly, that the results encompass 2018 to October 2023, so publications with relevant results may have been published before or after this time; however, the results are robust for the time period. Future meta-analyses can update the results, which will strengthen any results derived from the process. Second, many of the studies subjected to meta-analysis in previous studies include motor results, but lack reporting of cognitive outcomes using standardized tests (such as MoCA and Trail Making Test A). We hope more PD exercise studies include cognitive evaluation, which would also strengthen already-robust results.

Author Contributions

Conceptualization, S.O.A.; methodology, S.O.A. and D.S.; software, D.S., L.D., K.B. and E.S.; validation, S.O.A. and D.S.; formal analysis, S.O.A. and D.S.; writing—original draft preparation, S.O.A., D.S., L.D., K.B. and E.S.; writing—review and editing, S.O.A.; supervision, S.O.A. and D.S.; project administration, S.O.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding, therefore the funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Institutional Review Board Statement

Not applicable, secondary to being a synthesis of previously published studies.

Informed Consent Statement

Not applicable, as synthesis research is conducted with previously published and peer-reviewed studies.

Data Availability Statement

Data are contained within the article and all original articles are available via Ovid MEDLINE, SCOPUS, and CINAHL for the period from March 2018 to May 2023. Further inquiries can be directed to the corresponding author, S.A.

Acknowledgments

We would like to thank Emily Born, MOT, Julie Scheffler, MOT, Katie Vogel, MOT, and Jason Longhurst, who completed an earlier version of the motor outcomes of exercise and PD, who contributed to the database of exercise and PD outcomes.

Conflicts of Interest

Syed O. Ahmad is from Virginia Gore NeuroOccupation Lab, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The company had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Abbreviations

The following abbreviations are used in this manuscript:
PDParkinson’s Disease
ADAlzheimer’s Disease
BDNFBrain-derived Neurotrophic Factor
UPDRSUnified Parkinson’s Disease Rating Scale
MoCAMontreal Cognitive Assessment
MAPTMicrotubule-Associated Protein Tau
CIConfidence Interval

References

  1. Ahmad, S.O.; Longhurst, J.; Stiles, D.; Downard, L.; Martin, S. A meta-analysis of exercise intervention and the effect on Parkinson’s Disease symptoms. Neurosci. Lett. 2023, 801, 137162. [Google Scholar] [CrossRef] [PubMed]
  2. Ahmad, S.O.; Stiles, D.; Born, E.; Scheffler, J.; Vogel, K. Commentary on A Meta-Analysis of Exercise Intervention and the Effect on Parkinson’s Disease Symptoms: What Activities Are Best? Appl. Sci. 2024, 14, 7236. [Google Scholar] [CrossRef]
  3. Poplawska-Domaszewicz, K.; Qamar, M.A.; Pecurariu, C.F.; Chaudhuri, K.R. Recognition and characterising non-motor profile in early onset Parkinson’s disease (EOPD). Park. Relat. Disord. 2024, 129, 107123. [Google Scholar] [CrossRef]
  4. Popovic, Z.; Kuric, T.G.; Latic, I.R.; Matosa, S.; Sadikov, A.; Groznik, V.; Georgiev, D.; Tomic, S. Correlation between non-motor symptoms and eye movements in Parkinson’s disease patients. Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol. 2025, 46, 2665–2673. [Google Scholar] [CrossRef]
  5. Cass, S.P. Alzheimer’s Disease and Exercise: A Literature Review. Curr. Sports Med. Rep. 2017, 16, 19–22. [Google Scholar] [CrossRef]
  6. Augusto-Oliveira, M.; Arrifano, G.P.; Leal-Nazaré, C.G.; Santos-Sacramento, L.; Lopes-Araújo, A.; Royes, L.F.F.; Crespo-Lopez, M.E. Exercise Reshapes the Brain: Molecular, Cellular, and Structural Changes Associated with Cognitive Improvements. Mol. Neurobiol. 2023, 60, 6950–6974. [Google Scholar] [CrossRef] [PubMed]
  7. Zhang, S.; Gu, B.; Zhen, K.; Du, L.; Lv, Y.; Yu, L. Effects of exercise on brain-derived neurotrophic factor in Alzheimer’s disease models: A systematic review and meta-analysis. Arch. Gerontol. Geriatr. 2024, 126, 105538. [Google Scholar] [CrossRef] [PubMed]
  8. Zhao, R. Exercise mimetics: A novel strategy to combat neuroinflammation and Alzheimer’s disease. J. Neuroinflammation 2024, 21, 40. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  9. Baldassarre, I.; Rotondo, R.; Piccardi, L.; Leonardi, L.; Lanni, D.; Gaglione, M.; Stocchi, F.; Fini, M.; Goffredo, M.; Padua, E.; et al. The Effects of Multidisciplinary Intensive Rehabilitation on Cognitive and Executive Functions in Parkinson’s Disease: A Clinical Database Analysis. J. Clin. Med. 2024, 13, 3884. [Google Scholar] [CrossRef] [PubMed Central]
  10. Lin, Y.-P.; Lin, I.-I.; Chiou, W.-D.; Chang, H.-C.; Chen, R.-S.; Lu, C.-S.; Chan, H.-L.; Chang, Y.-J. Optimizing rehabilitation strategies in Parkinson’s disease: A comparison of dual cognitive-walking treadmill training and single treadmill training. Sci. Rep. 2024, 14, 25210. [Google Scholar] [CrossRef] [PubMed Central]
  11. Domingues, V.L.; Makhoul, M.P.; de Freitas, T.B.; Polese, J.C.; Silva-Batista, C.; Barbieri, F.A.; Torriani-Pasin, C. Factors Associated With Physical Activity and Sedentary Behavior in People With Parkinson Disease: A Systematic Review and Meta-Analysis. Phys. Ther. 2024, 104, pzae114. [Google Scholar] [CrossRef] [PubMed]
  12. Khan, A.; Ezeugwa, J.; Ezeugwu, V.E. A systematic review of the associations between sedentary behavior, physical inactivity, and non-motor symptoms of Parkinson’s disease. PLoS ONE 2024, 19, e0293382. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  13. Zhang, Y.; Liu, S.; Xu, K.; Zhou, Y.; Shen, Y.; Liu, Z.; Bai, Y.; Wang, S. Non-pharmacological therapies for treating non-motor symptoms in patients with Parkinson’s disease: A systematic review and meta-analysis. Front. Aging Neurosci. 2024, 16, 1363115. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  14. Chartier, C.; Godard, J.; Durand, S.; Humeau-Heurtier, A.; Menetrier, E.; Allain, P.; Besnard, J. Combinations of physical and cognitive training for subcortical neurodegenerative diseases with physical, cognitive and behavioral symptoms: A systematic review. Neurol. Sci. 2024, 45, 5571–5589. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  15. Murray, D.K.; Sacheli, M.A.; Eng, J.J.; Stoessl, A.J. The effects of exercise on cognition in Parkinson’s disease: A systematic review. Transl. Neurodegener. 2014, 3, 5. [Google Scholar] [CrossRef]
  16. Nasreddine, Z.S.; Patel, B.B. Validation of Montreal Cognitive Assessment, MoCA, Alternate French Versions—ERRATUM. Can. J. Neurol. Sci./J. Can. Sci. Neurol. 2023, 50, 161. [Google Scholar] [CrossRef]
  17. Islam, N.; Hashem, R.; Gad, M.; Brown, A.; Levis, B.; Renoux, C.; Thombs, B.D.; McInnes, M.D. Accuracy of the Montreal Cognitive Assessment tool for detecting mild cognitive impairment: A systematic review and meta-analysis. Alzheimer’s Dement. J. Alzheimer’s Assoc. 2023, 19, 3235–3243. [Google Scholar] [CrossRef]
  18. Xu, X.; Li, Y.; Wang, J.; Cao, Y.; Feng, C.; Guo, Y.; Zong, G.; Sun, L.; Gao, X. Family History of AD/Dementia, Polygenic Risk Score for AD, and Parkinson’s Disease. Mov. Disord. Clin. Pr. 2023, 10, 1787–1794. [Google Scholar] [CrossRef]
  19. Ohlei, O.; Sommerer, Y.; Dobricic, V.; Homann, J.; Deecke, L.; Schilling, M.; Bartrés-Faz, D.; Cattaneo, G.; Düzel, S.; Fjell, A.M.; et al. Genome-wide QTL mapping across three tissues highlights several Alzheimer’s and Parkinson’s disease loci potentially acting via DNA methylation. medRxiv 2023. medRxiv:2023.12.22.23300365. [Google Scholar]
  20. Walker, L.; Attems, J. Prevalence of Concomitant Pathologies in Parkinson’s Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms. J. Park. Dis. 2024, 14, 35–52. [Google Scholar] [CrossRef]
  21. van Wetering, J.; Geut, H.; Bol, J.J.; Galis, Y.; Timmermans, E.; Twisk, J.W.; Hepp, D.H.; Morella, M.L.; Pihlstrom, L.; Lemstra, A.W.; et al. Neuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies. Acta Neuropathol. Commun. 2024, 12, 73. [Google Scholar] [CrossRef]
  22. Abraham, A.; Hart, A.; Andrade, I.; Hackney, M.E. Dynamic Neuro-Cognitive Imagery Improves Mental Imagery Ability, Disease Severity, and Motor and Cognitive Functions in People with Parkinson’s Disease. Neural Plast. 2018, 2018, 6168507. [Google Scholar] [CrossRef]
  23. Elpidoforou, M.; Bakalidou, D.; Drakopoulou, M.; Kavga, A.; Chrysovitsanou, C.; Stefanis, L. Effects of a structured dance program in Parkinson’s disease. A Greek pilot study. Complement. Ther. Clin. Pr. 2022, 46, 101528. [Google Scholar] [CrossRef]
  24. Liu, H.-H.; Wang, R.-Y.; Cheng, S.-J.; Liao, K.-K.; Zhou, J.-H.; Yang, Y.-R. Effects of square-stepping exercise on executive function in individuals with Parkinson’s disease: A randomized controlled pilot study. Geriatr. Nurs. 2022, 47, 273–279. [Google Scholar] [CrossRef]
  25. Moratelli, J.; Alexandre, K.H.; Boing, L.; Swarowsky, A.; Corrêa, C.L.; Guimarães, A.C.d.A. Binary dance rhythm or Quaternary dance rhythm which has the greatest effect on non-motor symptoms of individuals with Parkinson’s disease? Complement. Ther. Clin. Pr. 2021, 43, 101348. [Google Scholar] [CrossRef]
  26. Michels, K.; Dubaz, O.; Hornthal, E.; Bega, D. “Dance Therapy” as a psychotherapeutic movement intervention in Parkinson’s disease. Complement. Ther. Med. 2018, 40, 248–252. [Google Scholar] [CrossRef]
  27. Frisaldi, E.; Bottino, P.; Fabbri, M.; Trucco, M.; De Ceglia, A.; Esposito, N.; Barbiani, D.; Camerone, E.M.; Costa, F.; Destefanis, C.; et al. Effectiveness of a dance-physiotherapy combined intervention in Parkinson’s disease: A randomized controlled pilot trial. Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol. 2021, 42, 5045–5053. [Google Scholar] [CrossRef]
  28. Lee, Y.-Y.; Tai, C.-H.; Fisher, B.E. Training in Varying Environmental Contexts Facilitates Transfer of Improved Gait Performance to New Contexts for Individuals With Parkinson Disease: A Randomized Controlled Trial. Arch. Phys. Med. Rehabil. 2022, 103, 1917–1923. [Google Scholar] [CrossRef]
  29. Burt, J.; Ravid, E.; Bradford, S.; Fisher, N.J.; Zeng, Y.; Chomiak, T.; Brown, L.; McKeown, M.J.; Hu, B.; Camicioli, R. The Effects of Music-Contingent Gait Training on Cognition and Mood in Parkinson Disease: A Feasibility Study. Neurorehabilit. Neural Repair 2020, 34, 82–92. [Google Scholar] [CrossRef]
  30. Valenzuela, C.S.M.; Moscardó, L.D.; López-Pascual, J.; Serra-Añó, P.; Tomás, J.M. Effects of Dual-Task Group Training on Gait, Cognitive Executive Function, and Quality of Life in People With Parkinson Disease: Results of Randomized Controlled DUALGAIT Trial. Arch. Phys. Med. Rehabil. 2020, 101, 1849–1856. [Google Scholar] [CrossRef]
  31. Hajebrahimi, F.; Velioglu, H.A.; Bayraktaroglu, Z.; Yilmaz, N.H.; Hanoglu, L. Clinical evaluation and resting state fMRI analysis of virtual reality based training in Parkinson’s disease through a randomized controlled trial. Sci. Rep. 2022, 12, 8024. [Google Scholar] [CrossRef]
  32. Wang, Z.; Pi, Y.; Tan, X.; Chen, R.; Liu, Y.; Guo, W.; Zhang, J. Effects of Wu Qin Xi exercise on reactive inhibition in Parkinson’s disease: A randomized controlled clinical trial. Front. Aging Neurosci. 2022, 14, 961938. [Google Scholar] [CrossRef]
  33. Kafle, A.; Rizvi, S.R. Effect of Wii-Based Motor and Cognitive Training on Activities of Daily Living in Patients with Parkinson’s Disease. Indian J. Physiother. Occup. Ther. Int. J. 2021, 15, 1–7. [Google Scholar] [CrossRef]
  34. Sacheli, M.A.; Neva, J.L.; Lakhani, B.; Msc, D.K.M.; Vafai, N.; Shahinfard, E.; English, C.; McCormick, S.; Dinelle, K.; Neilson, N.; et al. Exercise increases caudate dopamine release and ventral striatal activation in Parkinson’s disease. Mov. Disord. Off. J. Mov. Disord. Soc. 2019, 34, 1891–1900. [Google Scholar] [CrossRef]
  35. van der Kolk, N.M.; de Vries, N.M.; Kessels, R.P.C.; Joosten, H.; Zwinderman, A.H.; Post, B.; Bloem, B.R. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson’s disease: A double-blind, randomised controlled trial. Lancet Neurol. 2019, 18, 998–1008. [Google Scholar] [CrossRef] [PubMed]
  36. Song, J.; Paul, S.S.; Caetano, M.J.D.; Smith, S.; Dibble, L.E.; Love, R.; Schoene, D.; Menant, J.C.; Sherrington, C.; Lord, S.R.; et al. Home-based step training using videogame technology in people with Parkinson’s disease: A single-blinded randomised controlled trial. Clin. Rehabil. 2018, 32, 299–311. [Google Scholar] [CrossRef]
  37. Harper, S.A.; Dowdell, B.T.; Kim, J.H.; Pollock, B.S.; Ridgel, A.L. Non-Motor Symptoms after One Week of High Cadence Cycling in Parkinson’s Disease. Int. J. Environ. Res. Public Health 2019, 16, 2104. [Google Scholar] [CrossRef]
  38. King, L.A.; Mancini, M.; Smulders, K.; Harker, G.; Lapidus, J.A.; Ramsey, K.; Carlson-Kuhta, P.; Fling, B.W.; Nutt, J.G.; Peterson, D.S.; et al. Cognitively Challenging Agility Boot Camp Program for Freezing of Gait in Parkinson Disease. Neurorehabilit. Neural Repair 2020, 34, 417–427. [Google Scholar] [CrossRef]
  39. Silva-Batista, C.; Corcos, D.M.; Kanegusuku, H.; Piemonte, M.E.P.; Gobbi, L.T.B.; de Lima-Pardini, A.C.; de Mello, M.T.; Forjaz, C.L.; Ugrinowitsch, C. Balance and fear of falling in subjects with Parkinson’s disease is improved after exercises with motor complexity. Gait Posture 2018, 61, 90–97. [Google Scholar] [CrossRef]
  40. Higgins, J.P.T.; Thompson, S.G.; Deeks, J.J.; Altman, D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327, 557–560. [Google Scholar] [CrossRef]
  41. Huedo-Medina, T.B.; Sánchez-Meca, J.; Marín-Martínez, F.; Botella, J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol. Methods 2006, 11, 193–206. [Google Scholar] [CrossRef]
  42. Johansson, M.E.; Cameron, I.G.M.; Van der Kolk, N.M.; de Vries, N.M.; Klimars, E.; Toni, I.; Bloem, B.R.; Helmich, R.C. Aerobic Exercise Alters Brain Function and Structure in Parkinson’s Disease: A Randomized Controlled Trial. Ann. Neurol. 2022, 91, 203–216. [Google Scholar] [CrossRef] [PubMed]
  43. Ernst, M.; Folkerts, A.-K.; Gollan, R.; Lieker, E.; Caro-Valenzuela, J.; Adams, A.; Cryns, N.; Monsef, I.; Dresen, A.; Roheger, M.; et al. Physical exercise for people with Parkinson’s disease: A systematic review and network meta-analysis. Cochrane Database Syst. Rev. 2023, 1, CD013856. [Google Scholar] [CrossRef] [PubMed]
  44. Guo, X.; Yu, J.; Wang, R.; Peng, N.; Li, R. Deciphering the effect of phytosterols on Alzheimer’s disease and Parkinson’s disease: The mediating role of lipid profiles. Alzheimer’s Res. Ther. 2024, 16, 53. [Google Scholar] [CrossRef] [PubMed]
  45. Simuni, T.; Chahine, L.M.; Poston, K.; Brumm, M.; Buracchio, T.; Campbell, M.; Chowdhury, S.; Coffey, C.; Concha-Marambio, L.; Dam, T.; et al. A biological definition of neuronal α-synuclein disease: Towards an integrated staging system for research. Lancet Neurol. 2024, 23, 178–190. [Google Scholar] [CrossRef]
  46. Lin, J.; Ou, R.; Li, C.; Hou, Y.; Zhang, L.; Wei, Q.; Liu, K.; Jiang, Q.; Yang, T.; Xiao, Y.; et al. Evolution and Predictive Role of Plasma Alzheimer’s Disease-related Pathological Biomarkers in Parkinson’s Disease. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2023, 78, 2203–2213. [Google Scholar] [CrossRef]
  47. Liu, W.-S.; Zhang, Y.-R.; Ge, Y.-J.; Wang, H.-F.; Cheng, W.; Yu, J.-T. Inflammation and Brain Structure in Alzheimer’s Disease and Other Neurodegenerative Disorders: A Mendelian Randomization Study. Mol. Neurobiol. 2024, 61, 1593–1604. [Google Scholar] [CrossRef]
Neurosci 06 00046 g001
Figure 1. PRISMA flow diagram.
Figure 1. PRISMA flow diagram.
Neurosci 06 00046 g001
Neurosci 06 00046 g002
Figure 2. The forest plot for the meta-analysis of cognitive outcomes from all studies. Note. • = study effect size, ―•― = the black lines represent the Confidence Intervals (CI) of a study, ES ± CI represents the effect size and the 95% confidence interval of the study. EG = Experimental Group, CG = Control Group, ExF = exercise first group, EdF = education first group, TBR = two-beat rhythm, FBR = four-beat rhythm [22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39].
Figure 2. The forest plot for the meta-analysis of cognitive outcomes from all studies. Note. • = study effect size, ―•― = the black lines represent the Confidence Intervals (CI) of a study, ES ± CI represents the effect size and the 95% confidence interval of the study. EG = Experimental Group, CG = Control Group, ExF = exercise first group, EdF = education first group, TBR = two-beat rhythm, FBR = four-beat rhythm [22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39].
Neurosci 06 00046 g002
Table 1. Characteristics of studies included in meta-analysis.
Table 1. Characteristics of studies included in meta-analysis.
AuthorExercise GroupGroupDescriptionPD OutcomeTest IntervalTrail A/MoCA Pre-Test Mean (SD)Pre-Test Group Size (ni1)Trail A/MoCA Post-Test Mean (SD)Post-Test Group Size (ni2)
Abraham et al. (2018) [22]Dynamic Neuro-Cognitive ImageryEG2 h x dayTrail A2 weeks30.55 (10.19)1027.68 (7.06)10
DNI2 h x day 27.46 (10.33)1028.18 (7.03)10
Elpidoforou et al. (2022) [23]DanceEG60 min 2x/wkMoCA8 weeks23.92 (1.47)1627.15 (0.75)13
Liu et al. (2022) [24]EG60 min 2x/wk 8 weeks24.7 (3.7)1426.9 (2.3)14
CG60 min 2x/wk 26.1 (3.8)1426.4 (4.1)14
Moratelli et al. (2021) [25]Binary dance45 min 2x/wkMoCA12 weeks19.5 (5.33)1823.66 (4.51)18
Quaternary dance45 min 2x/wk 17.3 (6.35)1320.84 (6.55)13
Michels et al. (2018) [26]EG60 min 1x/wkMoCA10 weeks27 (2.18)927.44 (2.4)9
CG60 min 1x/wk 25.25 (1.5)424.75 (0.96)4
Frisaldi et al. (2021) [27]EG120 min
3x/wk		MoCA5 weeks26.08 (3.07)1927.11 (2.51)19
CG60 min
3x/wk		5 weeks25.68 (2.89)1926.55 (2.62)19
Lee et al. (2022) [28]Treadmill TrainingEG60 min 2x/wkMoCA8 weeks26.36 (0.66)2226.82 (0.64)22
CG60 min 2x/wk 26.35 (0.69)2327.39 (0.59)23
Burt et al. (2020) [29]EGminimum of 15 min 3x/wkMoCA12 weeks25.33 (4.12)1525 (2.33)15
CGminimum of 15 min 3x/wk 26.2 (2.46)1525.53 (2.61)15
San Martín Valenzuela et al. (2020) [30]EG60 min 2x wkTrial A10 weeks51.3 (28.1)2348.86 (14.91)23
CG60 min 2x wk 58.74 (45.46)1772.73 (42.65)17
Hajebrahimi et al. (2022) [31]Virtual RealityEG60 min 3x/wkMoCA4 weeks22.27 (2.19)1524.54 (1.5)11
CG60 min 3x/wk 22.76 (3.39)1523 (4.91)13
Wang et al. (2022) [32]Wu Qin Xi90 min 3x/wkMoCA24 weeks26.7 (1.55)3027.43 (2.11)23
Stretching90 min 3x/wk 27.5 (1.77)3027.05 (2.22)22
Kafle et al. (2021) [33]AerobicEG60 min 2x/wkMoCA7 weeks26.4 (4.88)3029.07 (4.54)30
CG60 min 2x/wk 26.27 (4.28)3027.93 (4.4)30
Sacheli et al. (2019) [34]EG40–60 min 3x/wkMoCA3 months27.94 (1.98)2027.53 (1.94)20
CG40–60 min 3x/wk 28.23 (1.48)1527.54 (2.57)15
Van der Kolk et al. (2019) [35]EG30–45 min 3x/wkMoCA6 months26.3 (2.2)6525.7 (0.5)65
CG30–45 min 3x/wk 26 (6.3)6525.9 (0.5)65
Song et al. (2018) [36]EGmin 15 min 3x/wkMoCA12 weeks26.4 (2.77)3127.3 (2.8)28
CGmin 15 min 3x/wk 26.5 (2.7)2926.7 (2.3)25
Harper et al. (2019) [37]CyclingEG40 min 3x/wkMoCA1 week25.7 (2.8)2025 (3.2)20
CGN/A 25.7 (3.2)1525.6 (3.3)15
King et al. (2020) [38]Agility Boot CampExercise First80 min 3x/wkMoCA6 weeks26.6 (3)2526.5 (3.1)23
Education First240 min /wk 24.3 (4.2)2123.9 (4.3)19
Silva-Batista et al. (2018) [39]Resistance TrainingRT60 min 2x/wkMoCA12 weeks21.8 (4.3)1322.2 (3)13
RT w/instability60 min 2x/wk 20.8 (3.2)1326.8 (2.4)13
CGn/a 22.7 (5.7)1321.6 (6.5)13
Note. Group refers to participant grouping type (EG = Experimental Group; CG = Control Group, DNI = Did Not Include). Description provides a brief explanation of the activity/exercise conducted in the study by each group. PD outcome refers to the cognitive measurement reported in the study. Test interval refers to how long the study/intervention was conducted/data were collected. Pre-test total n = 756; post-test total n = 721.
Table 2. Summary of effect size calculations for studies included in meta-analysis.
Table 2. Summary of effect size calculations for studies included in meta-analysis.
StudyExercise TypeGroupdiwidi2widiwi1.96 x SELCIUCI
Abraham et al. (2018) [22]Dynamic Neuro-Cognitive ImageryEG0.324.940.511.580.881.203.21
DNI−0.085.000.03−0.410.88−0.963.28
Elpidoforou et al. (2022) [23]DanceEG−0.137.160.11−0.910.73−0.865.72
Liu et al. (2022) [24]EG−0.096.990.05−0.600.74−0.835.54
CG−0.017.000.00−0.080.74−0.755.55
Moratelli et al. (2021) [25]Binary dance−0.198.960.33−1.730.65−0.857.67
Quaternary dance−0.196.470.22−1.200.77−0.964.96
Michels et al. (2018) [26]EG−0.024.500.00−0.070.92−0.942.69
CG0.022.000.000.041.39−1.37−0.72
Frisaldi et al. (2021) [27]EG−0.049.500.01−0.370.64−0.678.25
CG−0.039.500.01−0.320.64−0.678.25
Lee et al. (2022) [28]Treadmill TrainingEG−0.0211.000.00−0.190.59−0.619.84
CG−0.0411.500.02−0.450.58−0.6210.36
Burt et al. (2020) [29]EG0.017.500.000.100.72−0.706.10
CG0.037.500.010.190.72−0.696.10
San Martín Valenzuela et al. (2020) [30]EG0.1111.480.151.300.58−0.4610.35
CG−0.328.390.85−2.670.68−0.997.07
Hajebrahimi et al. (2022) [31]Virtual RealityEG−0.106.340.06−0.610.78−0.884.81
CG−0.016.960.00−0.070.74−0.755.51
Wang et al. (2022) [32]Wu Qin Xi−0.0313.020.01−0.350.54−0.5711.95
Stretching0.0212.690.000.210.55−0.5311.61
Kafle et al. (2021) [33]AerobicEG−0.1014.980.14−1.440.51−0.6013.99
CG−0.0614.990.06−0.920.51−0.5714.00
Sacheli et al. (2019) [34]EG0.0110.000.000.150.62−0.618.78
CG0.027.500.000.190.72−0.696.10
Van der Kolk et al. (2019) [35]EG0.0232.500.020.750.34−0.3231.82
CG0.0032.500.000.130.34−0.3431.83
Song et al. (2018) [36]EG−0.0314.710.02−0.490.51−0.5413.71
CG−0.0113.430.00−0.100.53−0.5412.38
Harper et al. (2019) [37]CyclingEG0.0310.000.010.280.62−0.598.78
CG0.007.500.000.030.72−0.716.10
King et al. (2020) [38]Agility Boot CampExercise First0.0011.980.000.050.57−0.5610.87
Education First0.029.970.000.170.62−0.608.76
Silva-Batista et al. (2018) [39]Resistance TrainingRT−0.026.500.00−0.120.77−0.794.99
RT w/instability−0.256.450.41−1.630.77−1.024.94
CG0.056.500.020.320.77−0.724.99
∑−1.07367.903.06−9.2524.37−23.67320.15
di = −0.03
CId95% = −0.03 ± 0.1
Q = 2.83
Note. di = unweighted effect size, wi = weighted effect size, EG = Experimental Group, CG = Control Group, DNI = Did Not Include, d = d-index, average weighted effect size for all studies, CId95% = 95% confidence interval for the average weighted d-index, Q = q-statistic, homogeneity analysis.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ahmad, S.O.; Stiles, D.; Brown, K.; Dillon, L.; Shroba, E. Meta-Analysis of Exercise Effects on Cognition in Persons with Parkinson’s Disease. NeuroSci 2025, 6, 46. https://doi.org/10.3390/neurosci6020046

AMA Style

Ahmad SO, Stiles D, Brown K, Dillon L, Shroba E. Meta-Analysis of Exercise Effects on Cognition in Persons with Parkinson’s Disease. NeuroSci. 2025; 6(2):46. https://doi.org/10.3390/neurosci6020046

Chicago/Turabian Style

Ahmad, Syed O., Dana Stiles, Kaylee Brown, Leah Dillon, and Eliza Shroba. 2025. "Meta-Analysis of Exercise Effects on Cognition in Persons with Parkinson’s Disease" NeuroSci 6, no. 2: 46. https://doi.org/10.3390/neurosci6020046

APA Style

Ahmad, S. O., Stiles, D., Brown, K., Dillon, L., & Shroba, E. (2025). Meta-Analysis of Exercise Effects on Cognition in Persons with Parkinson’s Disease. NeuroSci, 6(2), 46. https://doi.org/10.3390/neurosci6020046

Article Metrics

Back to TopTop